Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA)...
PF-114, an original drug product, was given the INN of Vamotinib by the World Health Organization at the 73d Consultation on International Nonproprietary Names...
Areplivir, included in the guidelines of the Ministry of Health of Russia for the treatment of COVID-19, received marketing authorization in Uzbekistan.
On August 4,...
The Ministry of Health of the Russian Federation has approved the original drug Levilimab (Russian trade name Ilsira) for the treatment of rheumatoid arthritis...